Edoxaban tosylate hydrate
CAS: 1229194-11-9
Ref. 3D-EZB19411
| 1g | 324.00 € | ||
| 2g | 487.00 € | ||
| 100mg | 105.00 € | ||
| 250mg | 144.00 € | ||
| 500mg | 195.00 € |
Product Information
- Edoxaban Tosylate Monohydrate
- Edoxaban4-methylbenzenesulfonate, hydrate (1:1:1)
- Ethanediamide, N<sup>1</sup>-(5-chloro-2-pyridinyl)-N<sup>2</sup>-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, 4-methylbenzenesulfonate, hydrate (1:1:1)
- N-(5-Chloropyridin-2-yl)-N′-((1S,2R,4S)-4-[(dimethyl amino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl)ethanediamide p-toluenesulfonate monohydrate
- N-(5-Chloropyridin-2-yl)-N′-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide mono(p-toluenesulfonate) monohydrate
Edoxaban tosylate hydrate is an anticoagulant that inhibits the activity of thrombin and factor Xa. It has a long half-life and does not undergo significant first-pass metabolism in the liver. Edoxaban tosylate hydrate is used for the prevention of stroke in patients with atrial fibrillation. It can be administered orally or by intravenous infusion, and its effect is monitored by measuring levels of the natriuretic peptide NT-proBNP. Edoxaban tosylate hydrate has a low potential for drug interactions, which may be due to its low protein binding affinity (less than 10%). This drug also inhibits P-glycoprotein, which may lead to bleeding complications.
Chemical properties
Technical inquiry about: 3D-EZB19411 Edoxaban tosylate hydrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
